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Aims: Firstly, to investigate the association between depression, anxiety and urinary incontinence (UI) in a 10-year
longitudinal study of women. Secondly, to investigate the association between possible differences in the stress- and
urgency components of UI and different severities of depression and anxiety by age groups.Methods: In a longitudinal,
population-based survey study, the EPINCONT part of the HUNT study in Norway, we analyzed questionnaire data on
UI, depression and anxiety from 16,263 women from 20 years of age. Amultivariate logistic regressionmodel was used to
predict the odds of developing anxiety and depression among the women with and without UI at baseline and the odds of
developingUI among thewomenwith andwithout anxiety or depression at baseline.Results: Forwomenwith anyUI at
baseline we found an association with the incidence of depression and anxiety symptoms, OR 1.45 (1.23–1.72) and 1.26
(1.8–1.47) for mild depression and anxiety respectively. For women with depression or anxiety symptoms at baseline we
found an association with the incidence of any UI with OR 2.09 (1.55–2.83) and 1.65 (1.34–2.03) for moderate/severe
symptom-score for depression and anxiety, respectively, for the whole sample. Conclusions: In this study, both
depression and anxiety are shown to be risk factors for developing UI with a dose-dependent trend. UI is associated with
increased incidence of depression and anxiety. Neurourol. Urodynam. 36:322–328, 2017.
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INTRODUCTION
Several epidemiologic cross-sectional studies have linked
depression to urinary incontinence (UI) in women. The
association has been shown to be strongest for urgency and
mixed incontinence and for severe incontinence.1–7 An
association between anxiety and UI has also been found.5,8,9
Anxiety, depression and UI are all common health problems,
and a possible link between them is of great interest. Studies
have given conflicting answers on the question of whether it is
anxiety and depression that give a higher risk of incidence of UI
or UI that gives a higher risk of developing anxiety and
depression.8,10–12 In addition to the epidemiological substrate,
there are also biological and neurological explanation models
for both directions of the associations. Serotonergic pathways
and the sympathetic nerve system are involved in both UI,
anxiety, and depression.10,13–15
Longitudinal studies are necessary to better understand the
underlying causes and sequences of the observed associations
in the cross-sectional studies. With data from the large
Norwegian EPINCONT study, based on the Nord-Trøndelag
Health Survey 2 and 3 (HUNT2 and HUNT3), the main objective
of the present study was to investigate the associations
between depression, anxiety and UI in women in a prospective
10-year follow-up study.
MATERIALS AND METHODS
The Nord-Trøndelag health study (HUNT) was a large
population-based survey, which all persons aged 20 years
and older in the county of Nord-Trøndelag were invited to
participate in. HUNT3 (2006–08) included the same questions
asHUNT2 (1995–97) on the topics of UI, anxiety and depression.
47,177 women were invited to participate in HUNT2, and
47,415 in HUNT3. The invitation included questionnaire one
(Q1), which the participants were asked to bring to a screening
station where several clinical examinations were done and
blood samples were drawn. The women who met inclusion
criteria at the screening station received questionnaire two
(Q2). In HUNT2, the questions about anxiety and depression
were inQ1 and the questions aboutUIwere inQ2. InHUNT3 the
questions in both of these areas were in Q2. 34,653 (73.5%)
answered Q1 in HUNT2. 80.8% of those who answered Q1
answered the incontinence part of the study in Q2 in HUNT2.
27,761 (58.7%) of those invited answered Q1and 21,804
answered Q2 in HUNT3. 16,253 women answered Q1 and Q2
in HUNT2 and Q2 in HUNT3, and our study was a longitudinal
survey of the women in this subgroup. Figure 1 is a
vizualization of the study-population of the women who
were invited to the HUNT-study until theywere included in the
study-group. For the analyses we used three age groups: 19–39
years, 40–54 years and 55 years and older.
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Urinary Incontinence Variables (EPINCONT Study)
The incontinence part of the questionnaire is known as
the EPINCONT study (Epidemiology of Urinary Incontinence
in Nord-Trøndelag).16 For analyses UI was defined as any
leakage of urine.17 If the answer to the entry question of
whether she had experienced leakage was yes, the woman
was asked to answer more specific questions about the
leakage of urine; how often (four levels), how much (three
levels) and in which situations she experienced the leakage. A
stress UI component was defined when the woman experi-
enced loss of urine when coughing, laughing, sneezing, or
making an effort. An urgency UI component was defined
when she experienced urgency to void. The incontinence was
classified as stress incontinence if she answered ‘‘yes’’ on the
stress component question and urgency incontinence if she
answered ‘‘yes’’ on the urgency component question. Mixed
UI was defined if she answered ‘‘yes’’ on both these questions.
Only stress and urgency UI components were used in the
analyses.
Anxiety and Depression Variables
Anxiety and depression was measured by the Hospital
Anxiety and Depression Scale (HADS).18,19 This is a self-
administered questionnaire consisting of 14 items, seven for
anxiety (HADS-A) and seven for depression (HADS-D). Each
item has four possible answers and is scored on a Likert
scale from 0 to 3. The item scores are added, giving subscales
from 0 (minimum symptom level) to 21 (maximum symptom
level).
The developers of the scale have recommended three cut-off
scores:mild (8–10), moderate (11–14), or severe (15–21) anxiety
or depression.18,20 Here the moderate and severe groups
(scores>11) are combined into a common ‘‘ moderate/severe’’
group. Data on the validity of HADS have been published.20–22
Statistical Analyses
All statistical analyses were performed using SPSS version
22.0. Statistical significance was accepted at a 5% level.
Logistic regression analyses were performed to investigate
the associations between anxiety and depression and UI.
Associations are shown as odds ratios (ORs) with 95%
confidence intervals (CIs). In the regression model we
adjusted for age, body mass index, parity, myocardial
infarction, cerebral stroke, asthma, and diabetes. Age was
used as a continuous variable, the other adjustment variables
were used as categorical variables.
To see if anxiety and depression could predict the onset of
UI during follow-up we first excluded women who had UI at
baseline. Then we made two groups of cases; those with
HADS-score 8–10 and those with HADS-score 11 at baseline.
Women with HADS< 8 were controls. Conversely, to see if UI
could predict the onset of anxiety and depression during
follow-up, we first excluded those women who had anxiety or
depression at baseline. Women with UI at baseline were now
the cases and the women without UI at baseline were the
controls.
Ethics
Approvals for the HUNT study were obtained from the
Regional and National ethics review board and from the
Norwegian Data Inspectorate.
RESULTS
Sixteen thousand two hundred and fifty-three women
answered the UI-questions and the questions concerning
anxiety and depression in both HUNT2 and HUNT3 and could
thus be included in the follow-up study.
Table I shows the characteristics of the included women at
baseline regarding UI, anxiety, depression, and the adjustment
variables used, in total and by the three age groups. Mean age
was 47 years, andmean number of childrenwas 2.1. Prevalence
of UI was 23.7%, highest among the middle-aged, and lowest
among the youngest. One in five reported a stress UI
component, again highest among the middle-aged, and least
in the youngest group. One in ten reported an urgency UI
component, this was highest among the eldest.
About one in ten had mild and about one in twenty had
moderate/severe levels of anxiety, with small differences
between age groups. Depression, however, showed increasing
prevalence by increasing age. The incidence of UI during the 10-
year follow-up period was 18.7%, highest for the stress UI
component and for the youngest age group. The 10-year
incidence was 7.6% and 2.5% for mild and moderate/severe
levels of anxiety, respectively, and 5.2% and 1.2% for mild and
moderate/severe levels of depression, respectively (Table I). The
incidences of anxiety and depression showed less variance by
age groups than for UI.
UI and Depression
Table II presents adjusted analyses from logistic regression
for the associations (ORs) between depression and the
incidence of any UI, a urgency UI component and a stress
UI component. We found a highly significant association
between developing UI and high depression score at baseline.
The associations are present in all three age groups and for
both urgency UI and stress UI components, but the
associations did not always reach statistical significance.
Fig. 1. Visualization of the study-population of women who were invited to
the HUNT-study until they were included in the study-group.
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TABLE II. Adjusted Analyses From Logistic Regression for the Associations Between Depression and the Incidence of Any UI, a Urgency UI Component and a
Stress UI Component









Number of women (N) OR 95%CI OR 95%CI OR 95%CI OR 95%CI
Incident any UI (N¼ 2,054)
HADS-D < 8 (N¼ 14,613) Ref. Ref. Ref. Ref.
HADS-D 8–10 (N¼ 1,057 1.62 1.11–2.36 1.30 0.92–1.83 1.33 0.93–1.89 1.38 1.13–1.69
HADS-D 11(N¼ 383) 1.84 0.99–3.40 2.07 1.28–3.34 2.54 1.51–4.27 2.09 1.55–2.84
Incident urgency UI component (N¼ 997)
HADS-D< 8 (N¼ 14,613) Ref. Ref. Ref. Ref.
HADS-D 8–10 (N¼ 1,057 1.60 0.95–2.69 1.27 0.80–2.02 1.66 1.11–2.50 1.50 1.15–1.94
HADS-D  11 (N¼ 383) 1.99 0.86–4.57 1.98 1.05–3.73 3.10 1.71–5.60 2.30 1.57–3.36
Incident stress UI component (N¼ 1,641)
HADS-D < 8 (N¼ 4,613) Ref. Ref. Ref. Ref.
HADS-D 8–10 (N¼ 1,057) 1.64 1.11–2.44 1.27 0.86–1.86 1.60 1.10–2.33 1.46 1.17–1.83
HADS-D 11 (N¼ 383) 1.83 0.95–3.52 2.56 1.57–4.18 2.21 1.21–4.03 2.22 1.60–3.08
Results are given as odds ratios (OR) with 95% confidence intervals (CI). The analyses are adjusted for age, body mass index, parity, myocardial infarction,
cerebral stroke, asthma, and diabetes.
TABLE I. Characteristics of the Included Women at Baseline, Shown in Total and by Three Age Groups









Number of women (N) N % N % N % N %
Urinary incontinence (UI)
Any UI 889 17.3 1753 27.7 1213 25.4 3856 23.7
Stress UI component 744 14.5 1567 24.8 1022 21.4 3334 20.5
Urgency UI component 334 6.5 645 10.2 617 12.9 1596 9.8
Mixed UI 252 4.9 533 8.5 533 11.2 1321 8.1
Other/unclassified 153 3.0 229 3.6 280 5.9 662 4.1
Anxiety
HADS-A 8–11 546 10.6 749 11.8 524 11.0 1821 11.2
HADS-A 11 265 5.1 388 6.1 252 5.3 905 5.6
Depression
HADS-D 8–11 202 3.9 434 6.9 421 8.8 1057 6.5
HADS-D 11 72 1.4 167 2.6 144 3.0 383 2.4
Parity
None 1037 20.1 301 4.8 321 6.7 1661 10.2
1 880 17.1 499 7.9 312 6.5 1691 10.4
2 1900 36.9 2626 41.5 1169 24.5 5695 35.0
 3 1303 25.3 2880 45.5 2929 61.3 7114 44.0
Body mass index
< 18.5 79 1.5 28 0.4 18 0.4 125 0.8
18.5–24.9 2978 57.9 2925 46.2 1434 30.0 7337 45.1
25.0–29.9 1523 29.6 2426 38.3 2208 46.2 6157 37.9
> 29.9 544 10.6 948 15.0 1106 23.1 2598 16.0
Incidence of UI
Any UI 895 22.2 665 15.9 492 17.9 2054 18.7
Stress UI component 753 19.4 528 13.0 358 13.7 1641 15.5
Urgency UI component 369 10.5 333 8.6 294 11.5 997 10.1
Incidence of anxiety
HADS-A 8–10 330 7.9 363 7.3 272 7.6 965 7.6
HADS-A 11 119 3.0 125 2.7 57 1.7 301 2.5
Incidence of depression
HADS-D 8–10 191 4.0 248 4.5 309 7.8 749 5.2
HADS-D 11 51 1.1 57 1.1 49 1.3 158 1.2
Asthma 403 7.8 453 7.2 374 7.8 1232 7.6
Myocardial infarction 2 0 11 0.2 76 1.6 89 0.5
Cerebral stroke 9 0.2 25 0.4 77 1.6 111 0.7
Diabetes 22 0.4 65 1.0 130 2.7 217 1.3
Results are given as N and percentages.
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The ORs were higher for HADS-D score 11 and over than for
HADS-D scores 8–10 for all age groups and for both types of
UI, thus indicating a ‘‘dose-dependent’’ trend. The highest OR
(3.07) was found for urgency UI and moderate/severe
depression in the oldest age group.
Table III shows adjusted analyses from logistic regression for
the associations (ORs) between anyUI, a urgency UI component,
and a stress UI component, and the incidence of mild and
moderate/severe levels of depression. We found that any UI, a
urgency UI component, and a stress UI component at baseline,
were all statistically significantly associated with the incidence
of MILD depression (HADS 8–10) in all age groups with the
highest ORs in the youngest age group. We also saw an
association with moderate/severe depression score, but these
results weremostly not significant. There were generally higher
ORs for a urgency UI component than for a stress UI component.
UI and Anxiety
Table IV shows adjusted analyses from logistic regression for
the associations (ORs) between anxiety and the incidence of
any UI, and urgency UI and stress UI components. As for
depression, we found a highly statistically significant associa-
tion between developing any UI and the two UI components
and having a high anxiety score at baseline. However, the
associations were not statistically significant in the oldest age
group for any UI category. The ORs were higher for HADS-A
score 11 and over than forHADS-A scores 8–10 for all age groups
and for both types of UI, thus indicating a ‘‘dose-dependent’’
trend. The highest OR (2.25) was found for a urgency UI
component and moderate/severe anxiety in the middle age
group.
Table V shows adjusted analyses from logistic regression for
the associations (ORs) between any UI, a urgency UI compo-
nent, and a stress UI component, and the incidence of mild and
moderate/severe levels of anxiety.
We found statistically significant associations between
the incidence of MILD anxiety (HADS-A 81–10) in the total
sample for women with any UI and stress and urgency UI
components at baseline. For the different age subgroups the
ORs for anxiety were generally lower than for depression. The
incidence of moderate/severe levels of anxiety was statisti-
cally significant only for a urgency UI component in the older
age group.
TABLE IV. Adjusted Analyses From Logistic Regression for the Associations Between Anxiety and the Incidence of Any UI, a Urgency UI Component and a
Stress UI Component









Number of women (N) OR 95%CI OR 95%CI OR 95%CI OR 95%CI
Incident any UI (N¼ 2,054)
HADS-A< 8 (N¼ 13,161) Ref. Ref. Ref. Ref.
HADS-A 8–10 (N¼ 1,821) 1.43 1.12–1.88 1.73 1.13–1.99 1.17 0.84–1.61 1.45 1.25–1.68
HADS-A 11(N¼ 905) 1.78 1.28–2.47 1.79 1.28–3.33 1.36 0.86–2.15 1.65 1.34–2.03
Incident urgency UI component (N¼ 997)
HADS-A< 8 (N¼ 13,161) Ref. Ref. Ref.
HADS-A 8–10 (N¼ 1,821) 1.53 1.10–2.14 1.81 1.31–2.51 1.30 0.88–1.92 1.54 1.26–1.88
HADS-A 11 (N¼905) 2.11 1.37–3.23 2.24 1.49–3.37 1.58 0.92–2.72 1.98 1.53–2.57
Incident stress UI component (N¼ 1,641)
HADS-A< 8 (N¼ 13,161) Ref. Ref. Ref. Ref.
HADS-A 8–10 (N¼ 1,821) 1.43 1.12–1.81 1.73 1.32–2.27 1.21 0.84–1.75 1.50 1.27–1.76
HADS-A 11 (N¼ 905) 1.78 1.28–2.49 1.96 1.38–2.79 1.47 0.89–2.44 1.75 1.41–2.19
Results are given as odds ratios (OR) with 95% confidence intervals (CI). The analyses are adjusted for age, body mass index, parity, myocardial infarction,
cerebral stroke, asthma and diabetes.
TABLE III. Adjusted Analyses From Logistic Regression for the Associations Between Any UI, Urgency and Stress UI Components and the Incidence of Mild
and Moderate/Severe Depression









Number of women (N) OR 95%CI OR 95%CI OR 95%CI OR 95%CI
Incident HADS-D 8–10 (N¼ 749)
Continence (N¼ 11,683) Ref. Ref. Ref. Ref.
Any UI (N¼ 3,856) 1.66 1.17–2.35 1.46 1.11–1.92 1.44 1.10–1.89 1.45 1.23–1.72
Urgency UI component (N¼ 1,596) 1.84 1.11–3.03 1.63 1.11–2.40 1.69 1.20–2.36 1.65 1.32–2.07
Stress UI component (N¼ 3,334) 1.66 1.15–2.41 1.45 1.09–1.94 1.45 1.08–1.93 1.45 1.21–1.73
Incident HADS-D 11 (N¼ 158)
Continence (N¼ 11,683) Ref. Ref.
Any UI (N¼ 3,856) 1.37 0.69–2.73 1.70 1.98–2.95 1.15 0.58–2.29 1.43 1.00-2.06
Urgency UI component (N¼ 1,596) 2.21 0.92–5.33 0.85 0.30–2.41 1.85 0.85–4.03 1.52 0.92–2.50
Stress UI component (N¼ 3,334) 1.19 0.54–2.60 1.85 1.05–3.26 1.03 0.48–2.22 1.40 0.95–2.06
Results are given as odds ratios (OR) with 95% confidence intervals (CI). The analyses are adjusted for age, body mass index, parity, myocardial infarction,
cerebral stroke, asthma and diabetes.
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Unadjusted results from logistic regression analyses for
Tables I–V are not shown due to very similar results and trends.
DISCUSSION
This study indicates that both depression and anxiety are
predictors for the onset of UI and that UI is a predictor for the
onset of both anxiety and depression in women from 20 years
of age. We investigated the association between the degree of
depression and anxiety score, the UI component, and age
group. With both depression and anxiety at baseline, the
association with the onset of UI is stronger with a higher
HADS-score. The highest ORs are found in the groups with
HADS-D and HADS-A11 at baseline developing a urgency UI
component, in the eldest group for depression score and in the
middle-aged group for anxiety. The association between
urinary incontinence at baseline and the incidence of anxiety
and depression is strongest with HADS 8–10 in the total
sample, and we see the highest ORs for a urgency UI
component.
In a large prospective study like ours the design indicates
more certain evidence than can be found in a cross-sectional
study, but the associations found are not proof of causality.
The strengths of the study include a population-based design
with a large sample size and a good response rate; as far as we
know one of the largest studies investigating this topic. All
adult women 20 years and older were invited to participate,
and results from the study give representative knowledge
about the entire adult female population. Most other studies
focus on elderly women only, or a more narrow age-group.
However, in our study we experienced problems with low
statistical power for small subgroups. We used validated scales
for UI, anxiety and depression and the HADS and UI questions
were part of a larger survey, which reduces the possibility of
both under- and over-reporting. The questionnaire with
symptom-based questions about UI is based on the definition
of the International Continence Society.17 The incidence of
urinary incontinence in the EPINCONT study is in the lower
range compared with incidences reported in other longitudinal
studies. This is discussed in another study from HUNT.23 The
HADS is widely used in population-based studies. A cut-off
score of eight on each subscale has been found to screen
adequately for case-level depression and anxiety according to
DSM-III/IV and ICD-8/9 diagnostic criteria.22 A cut-off of 11 is
also used to classify severity level.
Another strength of the study the ability to investigate the
associations between the two different components of UI, the
two severities of depression- and anxiety scores and the three
groups of age.
The limitations of the study include the potentially lower
participation in a mail-survey of the persons with the most
symptoms, especially very depressed women. 73.5% and 58.5%
of the invited personsmet the inclusion criteria at the screening
station in HUNT2 and HUNT3, respectively, and almost 80% of
those who received the questionnaire answered the EPINCONT
part. Even though the answering percentage is high, the lower
percentage of persons meeting inclusion criteria at the
screening station represents a possible selection bias. HADS
is not a diagnostic instrument even if it is a good tool to assess
symptom load.21 We know that there are possible shared
biological underliers for depression, anxiety and UI, and the
lack of information about psychiatric medication and medical
treatment of UI, represents a limitation. Lack of information
about functional loss could also be a limitation aswe know that
this is important in both UI and anxiety and depression. One
study found that only UIwith functional loss was a predictor of
anxiety after adjustments.24 The broad definition of UI used in
our studywill includemanywomenwith no bother or only low
bother due to their UI.
Depression and Anxiety at Baseline and Incident UI
We found a significant association between depression at
baseline and development of UI. The association was strongest
for the women with the highest HADS-score. This corresponds
well with the results of a 6-year longitudinal study10 where
they found an OR of 1.46 (1.08–1.97) of developing UI in the
group with major depression at baseline. That study was
limited by only including patients with a major depression
score and apopulation of only olderwomen. Our results are also
supported by an earlier study25 which found that women with
depression at baseline had a relative risk (RR) of 1.6 (1.2–2.0) of
being diagnosed with UI over a 9-year follow-up. That study
was limited to individuals with medical record diagnoses. In a
recent prospective study among young women, the women
with depressive symptoms or a history of depression were
more likely to develop UI symptoms during follow-up.26 A one-
year longitudinal study found that the incidence of cases of
urgency UI were predicted by anxiety at baseline, but not
depression.8 In a 5 year follow-up study investigating 475
TABLE V. Adjusted Analyses From Logistic Regression for the Associations Between Any UI, Urgency and Stress UI Components and the Incidence of Mild
and Moderate/Severe Anxiety









Number of women (N) OR 95%CI OR 95%CI OR 95%CI OR 95%CI
Incident HADS-A 8–10 (N¼ 965)
Continence (N¼ 11,683) Ref. Ref. Ref.
Any UI (N¼ 3,856) 1.24 0.92–1.67 1.33 1.05–1.69 1.24 0.93–1.66 1.26 1.08–1.47
Urgency UI component (N¼1,596) 1.23 0.77–1.96 1.38 0.97–1.95 1.61 1.13–2.30 1.42 1.14–1.77
Stress UI component (N¼ 3,334) 1.25 0.90–1.72 1.30 1.01–1.67 1.25 0.92–1.71 1.25 1.06–1.47
Incident HADS-A 11 (N¼ 158)
Continence (N¼ 11,683) Ref.
Any UI (N¼ 3,856) 1.37 0.85–2.20 0.93 0.61–1.42 1.30 0.71–2.41 1.12 0.84–1.48
Urgency UI component (N¼1,596) 1.84 0.96–3.53 0.64 0.29–1.39 2.55 1.32–4.94 1.33 0.90–1.96
Stress UI component (N¼ 3,334) 1.41 0.85–2.33 0.90 0.57–1.42 1.57 0.85–2.91 1.15 0.86–1.55
Results are given as odds ratios (OR) with 95% confidence intervals (CI). The analyses are adjusted for age, body mass index, parity, myocardial infarction,
cerebral stroke, asthma and diabetes.
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womenwithUI at baseline, the persistence ofUIwas associated
with depression symptoms. They also found that treatment of
UI did not affect the association.11 In a 18-year follow-up study
with a median follow-up of 12 years depressive symptoms
were associated with incidence of UI with a hazard ratio of 1.31
(1.09–1.56).12
There are fewer studies on anxiety as a risk factor for UI. In
one longitudinal study anxiety was both a risk factor and a
consequence of urgency incontinence.8 A longitudinal study
found a strong association between anxiety at baseline and UI
with incontinence-related functional loss. They did not find any
significant association with UI without function loss.25 A later
longitudinal study investigating the relationship between
anxiety disorder and UI, also found that persons with anxiety
at baseline had a significantly higher incidence of UI, but this
was only significant with condition-specific functional loss.27
In the present study, among those with anxiety at baseline
and an incidence of UI, there were higher ORs for developing a
urgency UI component compared to a stress UI component in
all age groups. This is similar to the strong association between
urgency UI and anxiety found in a cross-sectional study5 and a
longitudinal study.8
UI at Baseline and Incident Anxiety and Depression
We found an association between UI at baseline and the
incidence of depression, only significantwith amild depression
score (HADS 8–10), with the highest ORs for a urgency UI
component at baseline. One earlier study did not find this
association,10 but that study only investigated major depres-
sion, and thus might not catch the association with mild
depression. In another one year longitudinal study using HADS
and data on both stress and urgency UI at baseline, depression
was found to predict urgency UI, but not stress UI.8
Our study found an association between UI at baseline and
the onset of anxiety, alsomost significant for amildHADS-score
and with highest ORs for a urgency UI component in most age
groups. This corresponds with two other studies,8,27 but in
the latter the association was only significant when the UI was
accompanied with a condition-specific functional loss.27
No other study we know of has been able to differentiate
between severities of depression and anxiety in association
with UI. Our study indicates a ‘‘dose-response’’ effect in the
association between depression or anxiety at baseline and the
development UI. With UI at baseline the association with
the incidence of depression and anxiety is only significant with
a mild symptom score, but this could be a result of low
statistical power in the small subgroup.
Possible Mechanisms
Leakage represents loss of control, and the less predictable
the UI, themore disturbing it is for the person, which could lead
to helplessness, anxiety and depression.28 Dysfunctional beliefs
and automatic negative thoughts about social stigma could
lead to increased functional loss with increased anxiety
symptoms and sadness. Cognitive barriers may also decrease
a person’s benefit from treatment for UI.28 In one longitudinal
study depression at baselinewas associatedwith persistence of
UI.11 UI also often remains underdiagnosed because many
patients never consult a doctor for their problem.29 Depression
and anxiety could also contribute to a delay in help-seeking.
Having a chronic illness also in itself represents a burden that
could lead to sadness and depression. In addition, UI can lead to
social isolation and fewer outside activities, which may
contribute to depression.10,13
Serotonergic pathways are linked to both the regulation of
voiding function and depression. Serotonin inhibits the
micturition reflex pathway and facilitates the closure of the
urethral sphincter. The level of serotonin is low in clinically
depressed persons. Duloxetine is a serotonin and noradrenalin
reuptake inhibitor and has been shown to improve inconti-
nence and quality of life in patients with stress UI.15,30,31
CONCLUSIONS
In this large 10-year follow-up study of 16,253 women aged
20 years and older we found that women with depression or
anxiety at baseline were about 50% more likely to develop UI
during follow-up than other women, increasing with a high
HADS-score. UI at baseline was associated with developing
both anxiety and depression, with highest ORs for a mild to
moderate depression-score. We know that women with
comorbid depression or anxiety and UI have an increased
symptom burden from their conditions compared to women
with only one of the conditions, therefore it is important to be
aware of the association between the conditions, both as a
public-health priority and for physicians in their management
of such patients.
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